The store will not work correctly when cookies are disabled.
2-Benzylamino-1-propyl-1,4-dihydroquinazoline
ID: ALA3986997
PubChem CID: 134156428
Max Phase: Preclinical
Molecular Formula: C18H21N3
Molecular Weight: 279.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCN1C(NCc2ccccc2)=NCc2ccccc21
Standard InChI: InChI=1S/C18H21N3/c1-2-12-21-17-11-7-6-10-16(17)14-20-18(21)19-13-15-8-4-3-5-9-15/h3-11H,2,12-14H2,1H3,(H,19,20)
Standard InChI Key: GAWVUMJSGXMJIR-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
5.3136 -4.5988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0202 -4.1930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0235 -3.3759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3161 -2.9644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6095 -3.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9020 -2.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1913 -3.3685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1880 -4.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8954 -4.5971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6061 -4.1914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3102 -5.4159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0177 -5.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0143 -6.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7276 -4.6045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4342 -4.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1416 -4.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1424 -5.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8457 -5.8348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5565 -5.4291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5598 -4.6119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8524 -4.2004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
1 10 1 0
5 10 2 0
11 12 1 0
12 13 1 0
1 11 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
14 15 1 0
2 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.39 | Molecular Weight (Monoisotopic): 279.1735 | AlogP: 3.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 27.63 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.14 | CX LogP: 3.97 | CX LogD: 1.73 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.93 | Np Likeness Score: -0.86 |
References
1. McMullan M, García-Bea A, Miranda-Azpiazu P, Callado LF, Rozas I.. (2016) Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors' binding pocket., 123 [PMID:27474922] [10.1016/j.ejmech.2016.07.011] |